FKBP51 inhibition by SAFit2 modulates tau pathology and cognitive deficits in PS19 mice.
Overview
- Byrd Alzheimer’s Center and Research Institute, 4001 E. Fletcher Ave, Tampa, FL 33613 USA
- Department of Molecular Medicine, University of South Florida, 4202 E. Fowler Ave, Tampa, FL USA
- Department of Chemistry, University of South Florida, 4202 E. Fowler Ave, Tampa, FL USA
- Department of Molecular Biosciences, University of South Florida, 4202 E. Fowler Ave, Tampa, FL USA
- Research & Development, James A. Haley Veterans’ Hospital, 13000 Bruce B. Downs Blvd, Tampa, FL USA
Abstract
The accumulation of pathogenic tau protein is linked to cognitive decline and neuronal loss in Alzheimer’s disease (AD), with tau oligomers identified as particularly neurotoxic. The 51 kDa FK506-binding protein (FKBP51) stabilizes these toxic tau oligomers and has been identified as a risk factor for several neurodegenerative diseases. FKBP51 levels increase with age and are especially high in AD brains, suggesting its involvement in disease progression. The development of the selective FKBP51 inhibitor, SAFit2, which can cross the blood-brain barrier, has shown promise in reducing stress hormones, improving stress responses, and mitigating protein-related pathologies in other neurodegenerative models. However, the effects of SAFit2 on tauopathies, such as those seen in AD, have not yet been investigated. Here, the effects of the FKBP51-selective inhibitor, SAFit2, were evaluated in PS19 tau transgenic mice. Mice received a 28-day regimen of SAFit2, followed by comprehensive behavioral, neuropathological, and proteomic analyses. SAFit2 demonstrated effective brain penetrance, with sex-dependent pharmacokinetics. Treatment slowed cognitive decline and depressive-like behavior, with pronounced benefits in male PS19 mice, including improved spatial memory and reduced tau oligomer burden. In females, SAFit2 promoted clearance of AT8-positive tau multimers with some benefit to recognition memory. Proteomic profiling revealed distinct molecular signatures underlying these sex-specific responses: males exhibited upregulation of RNA processing and ribosomal proteins, while females showed restoration of calcium signaling and synaptic drivers. Notably, behavioral recovery occurred independently of widespread neuroinflammation reversal. These findings provide the first in vivo evidence that FKBP51 inhibition by SAFit2 induces sex-specific remodeling of the brain proteome. This study also provides further evidence for the therapeutic benefits of targeting FKBP51 for tauopathies.
Supplementary Information: The online version contains supplementary material available at 10.1186/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- figshare:33214358, at figshare; found in DataCite
Data availability
Data is provided within the manuscript or supplementary information files. The mass spectrometric data were deposited to Mass Spectrometry Interactive Virtual Environment (MassIVE), which is part of the ProteomeXchange Consortium, with the dataset identifier MSV000100258.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 12 authors, 6 keywords, 15 MeSH terms, 8 funders, 87 references, 14 RRIDs.
Cite
This paper
Contreras-Marciales, A., Mezquite-Garcia, D., Verdina, L. A., Elnahrawy, A., Wolf, T., Guergues, J., Parikh, P., Hunter, E. R., Hernandez Acosta, D., Stevens, S. M., Hill, S. E., & Blair, L. J. (2026). FKBP51 inhibition by SAFit2 modulates tau pathology and cognitive deficits in PS19 mice. Alzheimer's research & therapy, 18(1), 183. https://
BibTeX
@article{contrerasmarcia
author = {Contreras-Marciales, Andrea and Mezquite-Garcia, Daniela and Verdina, Laura A and Elnahrawy, Ahmed and Wolf, Tiara and Guergues, Jennifer and Parikh, Priyanshi and Hunter, Elle R and Hernandez Acosta, Diana and Stevens, Stanley M and Hill, Shannon E and Blair, Laura J},
title = {{FKBP51 inhibition by SAFit2 modulates tau pathology and cognitive deficits in PS19 mice}},
journal = {Alzheimer's research \& therapy},
year = {2026},
month = jun,
volume = {18},
number = {1},
pages = {183},
publisher = {BMC},
issn = {1758-9193},
doi = {10.1186/
url = {https://
pmid = {42251444},
pmcid = {PMC13463937}
}
RIS
TY - JOUR
AU - Contreras-Marciales, Andrea
AU - Mezquite-Garcia, Daniela
AU - Verdina, Laura A
AU - Elnahrawy, Ahmed
AU - Wolf, Tiara
AU - Guergues, Jennifer
AU - Parikh, Priyanshi
AU - Hunter, Elle R
AU - Hernandez Acosta, Diana
AU - Stevens, Stanley M
AU - Hill, Shannon E
AU - Blair, Laura J
TI - FKBP51 inhibition by SAFit2 modulates tau pathology and cognitive deficits in PS19 mice
T2 - Alzheimer's research & therapy
J2 - Alzheimers Res Ther
PY - 2026
DA - 2026/
VL - 18
IS - 1
SP - 183
SN - 1758-9193
PB - BMC
DO - 10.1186/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1186/
"type": "article-journal",
"title": "FKBP51 inhibition by SAFit2 modulates tau pathology and cognitive deficits in PS19 mice",
"container-title": "Alzheimer's research & therapy",
"author": [
{
"family": "Contreras-Marciales",
"given": "Andrea"
},
{
"family": "Mezquite-Garcia",
"given": "Daniela"
},
{
"family": "Verdina",
"given": "Laura A"
},
{
"family": "Elnahrawy",
"given": "Ahmed"
},
{
"family": "Wolf",
"given": "Tiara"
},
{
"family": "Guergues",
"given": "Jennifer"
},
{
"family": "Parikh",
"given": "Priyanshi"
},
{
"family": "Hunter",
"given": "Elle R"
},
{
"family": "Hernandez Acosta",
"given": "Diana"
},
{
"family": "Stevens",
"given": "Stanley M"
},
{
"family": "Hill",
"given": "Shannon E"
},
{
"family": "Blair",
"given": "Laura J"
}
],
"container-title-short":
"volume": "18",
"issue": "1",
"page": "183",
"DOI": "10.1186/
"PMID": "42251444",
"PMCID": "PMC13463937",
"ISSN": "1758-9193",
"publisher": "BMC",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
6
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1126/sciadv.add9789 [code]
- Chaperoning of specific tau structure by immunophilin FKBP12 regulates the neuronal resilience to extracellular stress.Journal: Science advancesIn common: Alzheimer's / dementia, cellular / molecular, 4 references, 2 authors
- [2] doi:10.1016/j.omtm.2022.09.007
- SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk.Journal: Molecular therapy. Methods & clinical developmentIn common: Alzheimer's / dementia, genetics / omics, mouse, 1 other category, 7 references, author Laura J Blair
- [3] doi:10.1073/pnas.2300722120
- Sex-specific and opposed effects of FKBP51 in glutamatergic and GABAergic neurons: Implications for stress susceptibility and resilience.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: cellular / molecular, 9 references
- [4] doi:10.1186/s13024-026-00928-2
- Tau oligomers modulate synapse fate by eliciting progressive bipartite synapse dysregulation and synapse loss.Journal: Molecular neurodegenerationIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 9 references
- [5] doi:10.1007/s00401-026-03018-1
- Tau oligomerization induces nuclear lamina invagination and chromatin remodeling in Alzheimer's disease.Journal: Acta neuropathologicaIn common: Alzheimer's / dementia, mouse, cellular / molecular, 7 references
- [6] doi:10.1016/j.mcpro.2025.101458 [code]
- Proximity Labeling of the Tau Repeat Domain Enriches RNA-Binding Proteins That Are Altered in Alzheimer's Disease and Related Tauopathies.Journal: Molecular & cellular proteomics : MCPIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 6 references
- [7] doi:10.1186/s13024-025-00817-0
- Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies.Journal: Molecular neurodegenerationIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 6 references
- [8] doi:10.1002/advs.76040
- Pharmacological Inhibition of FKBP51 Mitigates Early Life Adversity-Induced Social Deficits in Male Mice.Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)In common: genetics / omics, mouse, cellular / molecular, 5 references
- [9] doi:10.1177/13872877261416524
- Regional correlates of tau pathology and synaptic function in primary age-related tauopathy.Journal: Journal of Alzheimer's disease : JADIn common: Alzheimer's / dementia, cellular / molecular, 6 references
- [10] doi:10.1016/j.celrep.2025.116610 [code]
- Pathological tau alters head direction signaling and induces spatial disorientation.Journal: Cell reportsIn common: Alzheimer's / dementia, mouse, 6 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
